FilingSEC EDGAR6-K
Founder Dr. Michel Laberge Transitions from Chief Science Officer to Advisory Role
· SEC accepted
StageManagement Change
Filing content
Founder Dr. Michel Laberge has entered into an employment agreement to transition to a part-time advisory role as Founder Emeritus, effective November 1, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…